期刊
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
卷 52, 期 1, 页码 110-113出版社
ELSEVIER
DOI: 10.1016/j.jpba.2009.12.008
关键词
Moxifloxacin; Aqueous humor; Ultra high-pressure liquid chromatography; Nanoparticles; Ocular pharmacokinetics
资金
- Waters India Pvt Ltd.
The present report describes a rapid and sensitive ultra high-pressure liquid chromatography (UHPLC) method with UV detection to quantify moxifloxacin in rabbit aqueous humor. After deproteinisation with acetonitrile, gradient separation of moxifloxacin was achieved on a Waters Acquity BEH C18 (50 mm x 2.1 mm, 1.7 mu m) column at 50 degrees C. The mobile phase consisted of 0.1% trifluoroacetic acid in water and acetonitrile at a flow rate of 0.4 ml/min. Detection of moxifloxacin was done at 296 nm. Method was found to be selective, linear (r = 0.9997), accurate (recovery, 97.30-99.99%) and precise (RSD, <= 1.72%) in the selected concentration range of 10-1000 ng/ml. Detection and quantitation limit of moxifloxacin in aqueous humor were 0.75 and 2.5 ng/ml, respectively. The aqueous humor levels of moxifloxacin after single topical instillation in three formulations, i.e. moxifloxacin solution (Moxi-SOL), anionic nanoparticles (Moxi-ANP) and cationic nanoparticles (Moxi-CNP) were investigated. A fourfold increase in the relative bioavailability was observed with the Moxi-CNP (AUC(0 -> 1) 3.14 mu g h/ml) compared with Moxi-SOL (AUC(0 -> 1) 0.79 mu g h/ml) and Moxi-ANP (AUC(0 -> 1) 0.72 mu g h/ml) formulation. The results indicate that the cationic nanoparticle increases ocular bioavailability of moxifloxacin and prolong its residence time in the eye. (C) 2009 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据